Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT

NACompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

December 6, 2022

Study Completion Date

December 6, 2022

Conditions
In-stent Restenosis
Interventions
DEVICE

Optical Coherence Tomography (OCT)

"The OCT fibre is an optical fibre catheter containing a lens located at its extremity and positioned distal to the arterial segment to be examined. This is an intracoronary, very high-resolution section technique based on absorption and reflection of close infrared light by stents and tissues.~OCT analysis is performed during a usual coronary angiography procedure. It is a common technique already used and recommended for intrastent restenosis to establish the mechanism of the process. No new product is being tested. The examination performed is the same."

Trial Locations (27)

63000

CHU Clermont Ferrand, Clermont-Ferrand

Unknown

Université- Hôpital Leuven, Leuven

Clinique la Roseraie, Aubervilliers

CH Avignon, Avignon

CHRU Besançon, Besançon

CHU Bordeaux, Bordeaux

CHRU Morvan, Brest

Hôpital privé saint Martin, Cauro

Centre Hospitalier les Hôpitaux de Chartres, Chartres

CHRU Grenoble Alpes, Grenoble

Centre Hospitalier Départemental Vendée, La Roche-sur-Yon

CHRU Lille, Lille

Centre Hospitalier Saint Joseph Saint Luc, Lyon

Hospices Civiles Lyon, Lyon

AP-HM, Marseille

CHRU Nîmes, Nîmes

Polyclinique les fleurs, Ollioules

AP-HP, Paris

Hôpital Privé Institut Mutualiste Montsouris, Paris

CHRU Poitiers, Poitiers

Clinique Saint Hilaire, Rouen

CHRU Strasbourg, Strasbourg

Clinique Pasteur Toulouse, Toucy

CHRU Toulouse, Toulouse

CHRU Hôpitaux de Tours, Tours

CH de Bern, Bern

CHUV de Lausanne, Lausanne

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Corelab ISIT

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER